Linus Health is set to share exciting research at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) from March 17-21, 2026, in Copenhagen, Denmark. This conference gathers top minds—scientists, doctors, and industry leaders—to discuss the latest breakthroughs in brain health.
The focus of Linus Health’s presentations is on how digital cognitive assessments can improve the way we identify patients for new treatments and measure their progress. These methods can tailor care to what’s most important to the patient, making it more personal and effective.
Key Findings
Dr. Ali Jannati from Linus Health will present findings on how the Digital Clock and Recall (DCR) tool can help identify people in the early stages of Alzheimer’s who might benefit from treatments. This tool uses advanced machine learning and metrics to pinpoint candidates accurately.
Another significant study by Dr. Jannati shows how the Digital Assessment of Cognition (DAC) can predict Alzheimer’s risk by analyzing protein markers in the blood. This method allows for more targeted testing, which can speed up the research process and reduce unnecessary procedures.
Dr. Stina Saunders will discuss a digital tool called the Electronic Person Specific Outcome Measures (ePSOM), which captures what matters most to patients. This tool was tested on Japanese patients, demonstrating its acceptability and feasibility. It emphasizes that treatment plans should reflect patients’ unique needs and cultural backgrounds.
Linus Health is also promoting a multimodal platform combining cognitive, speech, and motor assessments. This comprehensive approach helps researchers identify candidates for clinical trials more efficiently and supports ongoing monitoring of patients throughout their care journey.
Experts believe that as more treatments for Alzheimer’s emerge, understanding the patient’s perspective is crucial. For instance, a study from the Alzheimer’s Association states that 90% of patients want their views to be considered in care planning. Keeping patients’ priorities at the forefront not only enhances care but also improves overall treatment outcomes.
Industry Trends
The conversation around digital health tools is growing. With more than 50% of clinical researchers using digital tools in their studies by 2023, it’s clear that technology is becoming a vital part of healthcare innovation.
As brain health continues to evolve, conferences like AD/PD provide a platform for sharing knowledge and best practices. The insights gained there can potentially lead to breakthroughs that benefit countless individuals struggling with cognitive disorders.
For more on these advancements, you can visit Linus Health’s website.
